Skip to content

Clinical trials

Phase 2 Mucopolysaccharidosis I trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Mucopolysaccharidosis I Phase: Phase 2 Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20081
20091
20142
20181

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Active, not recruiting1
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Masonic Cancer Center, University of Minnesota5
Genzyme, a Sanofi Company1
Magenta Therapeutics, Inc.1
Paul Szabolcs1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Mucopolysaccharidosis I8
Leukodystrophy, Globoid Cell5
Leukodystrophy, Metachromatic5
Mucopolysaccharidosis VI4
alpha-Mannosidosis4
Aspartylglucosaminuria3
Fucosidosis3
Mucopolysaccharidosis II3
Mucopolysaccharidosis VII3
Peroxisomal Disorders3

Trials

Showing 51 to 8 of 8. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.